NSAIDs and risk of lower gastrointestinal bleeding.
Rahme
Elham
E
Department of Medicine, McGill University, Montreal, QC, Canada. elham.rahme@mcgill.ca
Bernatsky
Sasha
S
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D000068579:Celecoxib; D003108:Colonic Diseases / Q000139:chemically induced / Q000517:prevention & control*; D004008:Diclofenac / Q000009:adverse effects; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D041741:Lower Gastrointestinal Tract / Q000187:drug effects*; D009853:Omeprazole / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy; D010438:Peptic Ulcer Hemorrhage / Q000517:prevention & control; D011720:Pyrazoles / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012307:Risk Factors; D013449:Sulfonamides / Q000009:adverse effects; D041742:Upper Gastrointestinal Tract / Q000187:drug effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000897:Anti-Ulcer Agents; D011720:Pyrazoles; D013449:Sulfonamides; D004008:Diclofenac; D000068579:Celecoxib; D009853:Omeprazole